Literature DB >> 9801109

Help-seeking decisions among men with impotence.

K S Ansong1, C Lewis, P Jenkins, J Bell.   

Abstract

OBJECTIVES: There is a paucity of valid contemporary data concerning the proportion of impotent men who seek treatment. The aim of this study was to determine the proportion of impotent men who sought treatment, from whom they sought treatment, and their reasons for seeking or not seeking treatment.
METHODS: A self-administered survey of 5198 randomly selected men between 50 and 76 years old, living in four rural counties in central New York State, was used.
RESULTS: The sample included 649 men who reported having experienced impotence in the 6 months preceding the study period (November 1996 to June 1997). The mean age of these men and mean duration of impotence were 64.5+/-7.2 and 4.9+/-4.6 years, respectively. Two hundred five men (31.6%) had sought treatment, 432 (66.6%) had not, and 12 (1.8%) neglected to answer the question. Most first consulted with either their primary care provider (44.7%) or a urologist (40.7%). Among those who had sought treatment, 36.3% were satisfied, 48.4% were dissatisfied, and 15.2% were neither satisfied nor dissatisfied with the results. The primary reasons for seeking treatment were to improve their self-esteem (44.8%), awareness of a new treatment (33.4%), partner insistence ( 11.3%), and coverage by their health insurance (10.4%). The reasons for not seeking treatment were embarrassment (29.8%), ignorance or misinformation (45.2%), and lack of affordability (25.0%).
CONCLUSIONS: Despite increased availability of effective treatment, most men with impotence do not seek treatment, and among those who do, only 36.3% are satisfied with the results.

Entities:  

Mesh:

Year:  1998        PMID: 9801109     DOI: 10.1016/s0090-4295(98)00397-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Symptom management strategies for men with early-stage prostate cancer: results from the Prostate Cancer Patient Education Program (PC PEP).

Authors:  Alok Vij; Marc A Kowalkowski; Tae Hart; Heather Honoré Goltz; David J Hoffman; Sara J Knight; Peter R Caroll; David M Latini
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

2.  Treatment expectations of men with ED and their female partners: an exploratory qualitative study based on grounded theory.

Authors:  S Henninger; C Höhn; C Leiber; M M Berner
Journal:  Int J Impot Res       Date:  2015-06-11       Impact factor: 2.896

3.  Endovascular therapy for vasculogenic erectile dysfunction.

Authors:  Jason H Rogers; Krishna J Rocha-Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

4.  Urinary incontinence in older people living in the community: examining help-seeking behaviour.

Authors:  Doreth Teunissen; Chris van Weel; Toine Lagro-Janssen
Journal:  Br J Gen Pract       Date:  2005-10       Impact factor: 5.386

5.  EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil.

Authors:  Giovanni Corona; Mario Maggi; Emmanuele A Jannini
Journal:  Sex Med       Date:  2017-12-21       Impact factor: 2.491

6.  Medical Help-Seeking for Sexual Concerns in Prostate Cancer Survivors.

Authors:  Melissa K Hyde; Leah Zajdlewicz; Addie C Wootten; Christian J Nelson; Anthony Lowe; Jeff Dunn; Suzanne K Chambers
Journal:  Sex Med       Date:  2016-01-11       Impact factor: 2.491

7.  Erectile Dysfunction: An Underestimated Presentation in Patients with Diabetes Mellitus.

Authors:  Zeeshan Anwar; Vishal Sinha; Sayantanava Mitra; Ashwani Kumar Mishra; Mahboobul Hasan Ansari; Abhishek Bharti; Vipin Kumar; Ashwini Kumar Nigam
Journal:  Indian J Psychol Med       Date:  2017 Sep-Oct

8.  Sexual dysfunction and health condition in Chinese doctor: prevalence and risk factors.

Authors:  Weiran Li; Shixing Li; Pengfei Lu; Haibin Chen; Yunyu Zhang; Yu Cao; Guanjian Li
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.